The Case for Expensive Antibiotics
A handful of years ago, a small pharmaceutical company quietly acquired the rights to an old but commonly used antibiotic. Few noticed until last week, when the new owner did something that’s recently become common in the world of pharmaceuticals: It abruptly raised the price. A lot. The manufacturer is called Nostrum Laboratories, and the drug for which it hiked the price—by more than 400 percent—is called nitrofurantoin.
In 1 playlist(s)
What's New With WIRED
The latest in-depth coverage covering the intersection of technology and culture. WIRED’s award-winn…Social links
Follow podcast
Recent clips
AI Can Give You an NPC That Remembers. It Could Also Get Your Favorite Artist Fired
08:11
This Disinformation Is Just for You
07:08
For the Love of God, Stop Microwaving Plastic
10:08